Notions which remain fixed as we move from model to model in the sense of "fixed" that we discussed in the last section have an "absolute" significance; notions which vary as we move from model to model have only a "relative" significance.
Given this, the Löwenheim-Skolem theorems show that the notions of countability and uncountability will in fact vary as we move from model to model.
Moving from Model 1 to Model 2, we added additional controls for maternal characteristics (employment status, marital status, nationality, and age) and for SRB seasonality (month of birth) (see Table 3).
Fitting models separately for pre- and post-progression utilities when including time to death yielded similar coefficients for pre-progression and post-progression - the consistency of parameter estimates and standard errors across models when including progression status (moving from Model 2 to Model 3) indicate low levels of multi-collinearity between progression status and time to death.
For each subscale there was some attenuation of effect in strength of coefficients for card holder status and reason for visit when comparing simpler models with more complex models (i.e., moving from model 1 through to model 4), but each effect remained statistically significant.
The brief introduction sets out the work's intellectual goals, moving from modelling individual behaviour to modelling the whole ecosystem, capturing emergent properties and predicting the behaviour of complex systems, in a bid to contribute to management of the Serengeti and other ecosystems.
This and other 2D studies paved the way for moving from modeling of idealized DES and physical systems to physiologically realistic scenarios which can propel the understanding of DES therapy for complex atherosclerotic disease.
The play shows how the Texan energy giant, Enron, moved from a model of the future to a bankrupt disaster with debts of $38bn.
Spanning a period from 1992 to 2001, it shows how the Texan energy giant moved from a model of the future to a bankrupt disaster with debts of $38bn£25bnbn).
As we moved from descriptive models to biologically grounded models, we began designing treatments that take advantage of the weaknesses of this cancer.
